Loading...
ICU Medical, Inc.
ICUI•NASDAQ
Healthcare
Medical - Instruments & Supplies
$129.90
$0.71(0.55%)
ICU Medical, Inc. (ICUI) Financial Performance & Income Statement Overview
Review ICU Medical, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.44%
↑ 5.44%
Operating Income Growth
88.23%
↑ 88.23%
Net Income Growth
-296.86%
↓ 296.86%
Operating Cash Flow Growth
22.76%
↑ 22.76%
Operating Margin
2.75%
↑ 2.75%
Gross Margin
35.11%
↑ 35.11%
Net Profit Margin
-3.87%
↓ 3.87%
ROE
-4.66%
↓ 4.66%
ROIC
1.83%
↑ 1.83%
ICU Medical, Inc. (ICUI) Income Statement & Financial Overview
Review ICU Medical, Inc.'s (ICUI) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $629.80M | $589.13M | $596.46M | $565.96M |
| Cost of Revenue | $402.55M | $384.28M | $389.03M | $382.69M |
| Gross Profit | $227.26M | $204.85M | $207.43M | $183.26M |
| Gross Profit Ratio | $0.36 | $0.35 | $0.35 | $0.32 |
| R&D Expenses | $22.36M | $21.03M | $23.39M | $21.84M |
| SG&A Expenses | $158.85M | $162.71M | $159.55M | $157.66M |
| Operating Expenses | $189.57M | $196.62M | $199.74M | $179.50M |
| Total Costs & Expenses | $592.11M | $580.89M | $588.76M | $562.19M |
| Interest Income | $2.73M | $2.60M | $2.81M | $2.65M |
| Interest Expense | $26.19M | $27.29M | $26.65M | $26.42M |
| Depreciation & Amortization | $52.99M | $55.60M | $55.32M | $55.53M |
| EBITDA | $87.42M | $64.96M | $79.81M | $53.14M |
| EBITDA Ratio | $0.14 | $0.11 | $0.13 | $0.09 |
| Operating Income | $37.69M | $8.24M | $7.69M | $3.77M |
| Operating Income Ratio | $0.06 | $0.01 | $0.01 | $0.007 |
| Other Income/Expenses (Net) | -$29.47M | -$26.16M | -$27.23M | -$26.11M |
| Income Before Tax | $8.22M | -$17.93M | -$19.53M | -$36.77M |
| Income Before Tax Ratio | $0.01 | -$0.03 | -$0.03 | -$0.06 |
| Income Tax Expense | $32.05M | $15.05M | $1.87M | $2.70M |
| Net Income | -$23.83M | -$32.98M | -$21.41M | -$39.47M |
| Net Income Ratio | -$0.04 | -$0.06 | -$0.04 | -$0.07 |
| EPS | -$0.97 | -$1.35 | -$0.88 | -$1.63 |
| Diluted EPS | -$0.97 | -$1.35 | -$0.88 | -$1.63 |
| Weighted Avg Shares Outstanding | $24.49M | $24.44M | $24.39M | $24.22M |
| Weighted Avg Shares Outstanding (Diluted) | $24.49M | $24.44M | $24.39M | $24.22M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan